Position in ADCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$125,579
-$264,612 QoQ
Shares Held
117,364
+12.8% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 113 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. ADCT ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in ADCT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $125,579 | 117,364 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $390,191 | 104,051 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $320,110 | 90,683 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $401,896 | 100,474 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $274,989 | 102,608 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $157,396 | 111,629 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $218,973 | 110,037 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $299,845 | 95,189 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $271,687 | 85,977 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||